Drawing for CONSULTATIONS IN ALLERGIES

USPTO serial 73799804

CONSULTATIONS IN ALLERGIES

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
MATTHEWS, AMOS
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CONSULTATIONS IN ALLERGIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JILL JARVIS-TONUS

SCOTIA PLZ 40 KING ST WSTE 4000 BOX 401TORONTO, ON M5H 3Y2

Goods and services

ClassDescriptionStatusFirst use
016MEDICAL AND SCIENTIFIC PERIODICALSABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 26, 1990ABN1ABANDONMENT - EXPRESS MAILED—
Jan 23, 1990CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 26, 1989CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 25, 1989CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 7, 1989DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance